WHO ICTRP trial
European/Australasian Stroke Prevention in Reversible Ischaemia Trial
ISRCTN73824458 · International Standard Randomised Controlled Trial Number (ISRCTN) · Not Recruiting
Key facts
| Trial ID | ISRCTN73824458 |
|---|---|
| Public title | European/Australasian Stroke Prevention in Reversible Ischaemia Trial |
| Scientific title | European/Australasian Stroke Prevention in Reversible Ischaemia Trial: ESPIRIT |
| Primary sponsor | University Medical Center Utrecht (Netherlands) |
| Registry | International Standard Randomised Controlled Trial Number (ISRCTN) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Not Specified |
| Countries | Netherlands |
| Conditions | Ischaemia Circulatory System Transient ischaemic attack |
| Interventions | Secondary prevention after transient ischaemic attack or non-disabling ischaemic stroke. Three treatment strategies: 1. Oral anticoagulation (international normalised ratio [INR] 2.0-3.0) 2. The combination of aspirin (acetylsalicylic acid… |
| Registration date | Sep 28, 2004 |
| Target size | 2739 |
| Secondary IDs | NCT00161070;N/A |
| Registry page | isrctn.com |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: